## EMN: Eastman Chemical Company - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 -0.2% below STRENGTH zone (4.0-10.0%); PEG 3.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($57.59)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 5)

**1. Eastman Chemical Boosts Dividend Leveraging Strong Cash Generation**
- Source: TradingView | 20251205T140811 | Neutral | Relevance: 100%
- Eastman Chemical Company has announced its 16th consecutive annual dividend increase, raising its quarterly cash dividend from 83 cents to 84 cents per share. This decision is backed by strong operating cash flow of $402 million in the third quarter and continued focus on cost discipline and cash generation, despite facing near-term challenges from soft demand. The company expects a gradual recovery and forecasts operating cash flow to approach $1 billion for the full-year 2025.

**2. Value Fund Dumps $10.1 Million Eastman Chemical Stake as Stock Slump Continues and EBIT Drops 43%**
- Source: The Globe and Mail | 20251205T110808 | Bearish | Relevance: 100%
- Atlantic Investment Management fully exited its $10.1 million position in Eastman Chemical Company (EMN) in the third quarter due to the stock's continued slump and a significant drop in EBIT. The fund sold 134,710 shares, marking a complete divestment as Eastman Chemical's revenue declined by 11% and EBIT fell 43% year-over-year. Despite strong cash flow generation and cost-cutting measures, the stock has underperformed, prompting the value investor to seek better opportunities elsewhere.

**3. Eastman Chemical raises quarterly dividend by 1.2% to $0.84/share**
- Source: MSN | 20251205T030816 | Bullish | Relevance: 100%
- Eastman Chemical Company has announced an increase in its quarterly dividend by 1.2%, raising it from $0.83 to $0.84 per share. This marks the company's 11th consecutive annual dividend increase. The new dividend is payable on January 10, 2025, to shareholders of record as of December 16, 2024.

**4. Value Fund Dumps $10.1 Million Eastman Chemical Stake as Stock Slump Continues and EBIT Drops 43%**
- Source: The Globe and Mail | 20251205T000823 | Bearish | Relevance: 100%
- Atlantic Investment Management fully exited its $10.1 million position in Eastman Chemical Company during the third quarter, selling 134,710 shares. This divestment occurred as Eastman Chemical's stock has underperformed, dropping 41% over the past year, and the company reported an 11% revenue decline and a 43% drop in EBIT. The move suggests a value investor sees better opportunities elsewhere despite Eastman's strong cash flow and cost-tightening efforts.

**5. Value Fund Dumps $10.1 Million Eastman Chemical Stake as Stock Slump Continues and EBIT Drops 43%**
- Source: The Globe and Mail | 20251204T230744 | Bearish | Relevance: 100%
- Atlantic Investment Management fully exited its position in Eastman Chemical Company (NYSE: EMN) during the third quarter, selling 134,710 shares worth approximately $10.1 million. This decision follows Eastman's significant stock decline of 41% over the past year and an 11% revenue decrease with a 43% drop in EBIT to $188 million. Despite strong operating cash flow and cost-cutting measures, analysts suggest the exit signals investor concerns about the company's performance amidst soft market demand.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-11 | Evercore ISI Gr | $70 | $75 | -7% |
| 2025-11-05 | UBS | $73 | $75 | -3% |
| 2025-11-05 | Wells Fargo | $70 | $80 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-11 | Evercore ISI Gr | main | In-Line |
| 2025-11-05 | UBS | main | Buy |
| 2025-11-05 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 11 ($0.08M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.2%)
- Blackrock Inc.: 7.0% (+0.9%)
- State Street Corpora: 5.0% (+24.3%)
- Capital Research Glo: 3.7% (-1.0%)
- Dimensional Fund Adv: 3.5% (+14.4%)

### Key Risks

1. Valuation risk: PEG 3.7x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 16.4% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.74 signals overvaluation risk, limited margin of safety. Forward P/E 10.0x attractive for 13% earnings growth. Analyst sentiment negative (3 target cuts vs 0 raises). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $7.3B |
| Beta | 1.25 |
| 52W Range | $56.11 - $103.82 |
| Short Interest | 5.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.74 |
| Forward P/E | 10.0 |
| Current P/E | 11.3 |
| YoY Growth | 13.4% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 2.2% to -0.2% (-2.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.2pp (needs >4.0% for momentum thesis). Below SMA200 (0.84x), long-term trend not supportive. RSI neutral at 53. OFD pattern: +DUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.20% (CS: 52) | Neutral |
| RSI_14 | 53.0 | Neutral |
| MACD Histogram | 0.33 | Bullish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 1.008x | Above |
| vs SMA200 | 0.836x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $61.53
- **Stop Loss:** $57.59 (6.4% risk)
- **Target:** $65.47 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 126
- **Position Value:** $7,752.78
- **Portfolio %:** 7.75%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-01-29 (Est: $0.81)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.17 | $1.14 | -2.2% |
| 2025Q2 | $1.75 | $1.60 | -8.7% |
| 2025Q1 | $1.89 | $1.91 | +1.2% |
| 2024Q4 | $1.57 | $1.87 | +18.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*